365 related articles for article (PubMed ID: 33308936)
1. Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory.
Carcaterra M; Caruso C
Med Hypotheses; 2021 Jan; 146():110412. PubMed ID: 33308936
[TBL] [Abstract][Full Text] [Related]
2. Alveolar type II cells and pulmonary surfactant in COVID-19 era.
Calkovska A; Kolomaznik M; Calkovsky V
Physiol Res; 2021 Dec; 70(S2):S195-S208. PubMed ID: 34913352
[TBL] [Abstract][Full Text] [Related]
3. The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho AF; Maes M; Walder K; Berk M
Life Sci; 2020 Oct; 258():118166. PubMed ID: 32739471
[TBL] [Abstract][Full Text] [Related]
4. Rationale for targeting complement in COVID-19.
Polycarpou A; Howard M; Farrar CA; Greenlaw R; Fanelli G; Wallis R; Klavinskis LS; Sacks S
EMBO Mol Med; 2020 Aug; 12(8):e12642. PubMed ID: 32559343
[TBL] [Abstract][Full Text] [Related]
5. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
[TBL] [Abstract][Full Text] [Related]
6. Distinctive features of severe SARS-CoV-2 pneumonia.
Budinger GRS; Misharin AV; Ridge KM; Singer BD; Wunderink RG
J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34263736
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
8. Preventing the development of severe COVID-19 by modifying immunothrombosis.
Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho A; Maes M; Walder K; Berk M
Life Sci; 2021 Jan; 264():118617. PubMed ID: 33096114
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis.
Singh L; Bajaj S; Gadewar M; Verma N; Ansari MN; Saeedan AS; Kaithwas G; Singh M
Front Immunol; 2021; 12():660632. PubMed ID: 34305892
[TBL] [Abstract][Full Text] [Related]
10. The Role of Macrophages in the Pathogenesis of SARS-CoV-2-Associated Acute Respiratory Distress Syndrome.
Kosyreva A; Dzhalilova D; Lokhonina A; Vishnyakova P; Fatkhudinov T
Front Immunol; 2021; 12():682871. PubMed ID: 34040616
[TBL] [Abstract][Full Text] [Related]
11. Dehydrozingerone ameliorates Lipopolysaccharide induced acute respiratory distress syndrome by inhibiting cytokine storm, oxidative stress via modulating the MAPK/NF-κB pathway.
Tirunavalli SK; Gourishetti K; Kotipalli RSS; Kuncha M; Kathirvel M; Kaur R; Jerald MK; Sistla R; Andugulapati SB
Phytomedicine; 2021 Nov; 92():153729. PubMed ID: 34517257
[TBL] [Abstract][Full Text] [Related]
12. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
[TBL] [Abstract][Full Text] [Related]
13. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies.
FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM
Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.
Borges L; Pithon-Curi TC; Curi R; Hatanaka E
Mediators Inflamm; 2020; 2020():8829674. PubMed ID: 33343232
[TBL] [Abstract][Full Text] [Related]
15. The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients.
Hariharan A; Hakeem AR; Radhakrishnan S; Reddy MS; Rela M
Inflammopharmacology; 2021 Feb; 29(1):91-100. PubMed ID: 33159646
[TBL] [Abstract][Full Text] [Related]
16. Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice.
Bi Z; Hong W; Que H; He C; Ren W; Yang J; Lu T; Chen L; Lu S; Peng X; Wei X
Signal Transduct Target Ther; 2021 Dec; 6(1):439. PubMed ID: 34952899
[TBL] [Abstract][Full Text] [Related]
17. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
[TBL] [Abstract][Full Text] [Related]
18. A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
Panda R; Castanheira FV; Schlechte JM; Surewaard BG; Shim HB; Zucoloto AZ; Slavikova Z; Yipp BG; Kubes P; McDonald B
JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34908534
[TBL] [Abstract][Full Text] [Related]
19. A molecular single-cell lung atlas of lethal COVID-19.
Melms JC; Biermann J; Huang H; Wang Y; Nair A; Tagore S; Katsyv I; Rendeiro AF; Amin AD; Schapiro D; Frangieh CJ; Luoma AM; Filliol A; Fang Y; Ravichandran H; Clausi MG; Alba GA; Rogava M; Chen SW; Ho P; Montoro DT; Kornberg AE; Han AS; Bakhoum MF; Anandasabapathy N; Suárez-Fariñas M; Bakhoum SF; Bram Y; Borczuk A; Guo XV; Lefkowitch JH; Marboe C; Lagana SM; Del Portillo A; Tsai EJ; Zorn E; Markowitz GS; Schwabe RF; Schwartz RE; Elemento O; Saqi A; Hibshoosh H; Que J; Izar B
Nature; 2021 Jul; 595(7865):114-119. PubMed ID: 33915568
[TBL] [Abstract][Full Text] [Related]
20. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
